Skip to content
777 Sourcing.

Capability

drug target discovery

Suppliers
2
States & provinces
2
Countries
1

2 drug target discovery suppliers across 2 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

BULLFROG AI HOLDINGS INC

BOYDS, MD

BullFrog AI Holdings, Inc. (NASDAQ: BFRG) uses explainable AI and machine learning to accelerate drug discovery and development for biopharma teams. Its platform combines biology-aware data harmonization, Causal AI analytics, and structured, auditable decision support to turn multi-omic and clinical data into patient subgroups, translational signals, and candidate rankings. bfLEAP® was developed in partnership with Johns Hopkins University Applied Physics Laboratory, and its neuroscience data infrastructure is built with the Lieber Institute for Brain De

Causal AI analyticsdata harmonizationdecision supportexplainable AImachine learningpatient stratificationpatient subgroup discovery

Compiled from public sources

ENVISAGENICS INC

LONG ISLAND CITY, NY

Envisagenics is a biotechnology company that uses its AI platform, SpliceCore®, to power the discovery and therapeutic targeting of RNA splicing. Combining expertise in RNA biology and AI, the company discovers novel, disease-specific drug targets in immuno-oncology and RNA-targeted treatments for neurodegenerative diseases. Founded in 2014, it is based in Long Island City, New York.

AI-driven analysis of RNA splicingRNA biologytherapeutic development

Compiled from public sources

Related capabilities

Other processes offered by the shops that list drug target discovery.

Browse all capabilities